awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35808422-0641E9B0-EF3F-4919-9281-7B7B3300AC34
Q35808422-0641E9B0-EF3F-4919-9281-7B7B3300AC34
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35808422-0641E9B0-EF3F-4919-9281-7B7B3300AC34
Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone
P2860
Q35808422-0641E9B0-EF3F-4919-9281-7B7B3300AC34
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35808422-0641E9B0-EF3F-4919-9281-7B7B3300AC34
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e3ecbe9f0e03c2b496bf55e80f909d0ee61f9621
P2860
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.